Skip to main content

Table 1 Comparison of clinicopathological parameters in cases with or without ALK fusion

From: Allelotypes of lung adenocarcinomas featuring ALK fusion demonstrate fewer onco- and suppressor gene changes

 

with fusion

without fusion

P

n

35

95

 

Age (years)

58.5

62.8

0.050

gender

   

   male

14

47

0.337

   female

21

48

 

smoking

   

   never

25

41

0.004

   ever

10

54

 

pStage

   

   I

20

60

0.532

   II-IV

15

35

 

differentiation grade

   

   wel

4

44

<0.001

   mod+por

31

51

 

Predominant subtype

   

   papillary

21

77

0.019

   Acinar

13

13

 

   Bronchioloalveolar

0

4

 

   solid with mucin

0

1

 

   signet

1

0

 

lymphatic invasion

   

   -

24

68

0.738

   +

11

27

 

Vessel invasion

   

   -

15

51

0.273

   +

20

44

 

TP53 mutation

   

   -

34

75

0.014

   +

1

20

 

EGFR mutation

   

   -

35

40

<0.0001

   +

0

55

 

KRAS mutation

   

   -

35

88

0.189

   +

0

7

Â